The purpose of this Biomarkers Commercialisation Summit is to support researchers of the CRUK Biomarker Centre and the Manchester Cancer Research Centre to explore pathways to translate their biomarkers and diagnostics research towards clinical use and market adoption.
- Conference
- biomodal presenter
Cancer Research Horizons Biomarkers Summit
Learn about our new 5-letter sequencing technology – duet multiomics solution +modC – and discover the combinatorial power of genetics and epigenetics.
17 November 2023
to 17 November 2023
Cancer Research UK Centre
, Manchester
Visit biomodal at booth
#NA
About the event
Presenting at the event
Considerations for Commercialising Multimodal Diagnostics
Paidi Creed
Senior Director, Computational Technologies
biomodal
11.45am - 12.15pm
Presentation abstract
Review specific considerations for multimodal software-based diagnostics.
Panel Discussion: Taking a Diagnostic to Market - Industry Perspective
Paidi Creed
Senior Director, Computational Technologies
biomodal
3.00pm - 3.45pm
Presentation abstract
The aim of this panel is to provide practical insights for researchers considering or already engaged in research translation and technology licensing, highlighting the opportunities and challenges associated with this path.
Find the venue
One sample. One workflow. One solution.
Here are the relevant biomodal resources for information. Find poster presentation information, case studies, interviews, and more.
